HealthQuill Health
A 15-minute fast walk helped reduce mortality by 20%, mostly in low-income Black individuals in the US, a study finds.
Health Medical Research

A 15-minute brisk walk may cut mortality rate by 20%: Vanderbilt

A 15-minute fast walk helped reduce mortality by 20%, mostly in low-income Black individuals in the US, a study finds.

Read More
The US Food and Drug Administration has approved Nuvation Bio Inc.’s medicine for adults who have a rare type of lung cancer caused by a specific genetic change.
Health Research

Physicians using AI viewed as less competent and trustworthy

HQ Team August 2, 2025: A new study conducted by Moritz Reis from the University of Wuerzburg in Germany and colleagues has shed.

Read More
Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug to treat neurodegenerative disease, amyotrophic lateral sclerosis.
Health Research

Not all low-grade prostate cancers are low risk: New study finds 30% risk

HQ Team August 2, 2025: A study published in JAMA Oncology is challenging the conventional belief that men diagnosed with Grade Group One.

Read More
The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious kidney diseases.
Drugs Health Pharma

FDA approves Apellis’ therapy to treat two serious, rare kidney diseases

HQ Team July 30, 2025: The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious.

Read More
Dementia patients are diagnosed on average 3.5 years after symptoms are first noticed, and it takes an even longer time for patients with early-onset of the disease, a global study by researchers at the University College London finds.
Health Medical Research

Dementia diagnosis takes 3.5 years after first symptoms surface: UCL study

HQ Team July 29, 2025: Dementia patients are diagnosed on average 3.5 years after symptoms are first noticed, and it takes an even.

Read More
The US Food and Drug Administration cleared PTC Therapeutics’ sepiapterin for treating children and adults with a rare genetic condition where the body cannot break down a part of protein called phenylalanine, which comes from foods like meat, eggs, and milk.
Drugs Health Pharma

US regulator clears PTC’s medicine to treat a rare genetic metabolic disease 

HQ Team July 29, 2025: The US Food and Drug Administration cleared PTC Therapeutics’ sepiapterin for treating children and adults with a rare.

Read More
Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the Chinese company’s 12 potential medicines.
Drugs Health Pharma

GSK inks $500m deal with Jiangsu Hengrui for 12 potential medicines

HQ Team July 28, 2025: Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the.

Read More
Dopamine rush, brain’s mirror games may help ‘you become what you think’
Health Medical Opinion

Brain’s mirror games may help ‘you become what you think’

By Aparna S. July 28, 2025: Phrases like ‘thoughts become things’ and ‘you become what you think’ are catchy slogans popularised by many motivational.

Read More
At least 24 children under the age of five died of malnutrition this month in the conflict-ridden Gaza Strip, taking the overall total of such deaths to 63 in July, according to the World Health Organization.
Drugs Health Medical

Malnutrition claims lives of 24 children in Gaza Strip, hospital cases surge

HQ Team July 28, 2025: At least 24 children under the age of five died of malnutrition this month in the conflict-ridden Gaza.

Read More
Vicebio will receive potential milestone payments of up to $450 million based on development and regulatory achievements.
Drugs Health Pharma

Sanofi to acquire UK’s Vicebio for $1.6b, to pocket vaccine candidates

 HQ Team July 22, 2025: Sanofi SA will acquire UK-based Vicebio Ltd. for $1.6 billion to gain access to vaccine candidates for respiratory.

Read More